4
Changes in Ownership
Edgewise Therapeutics, Inc. Filed Acc 0001562180-22-006557
General Counsel sold 4,730 shares at an average $10.91 ($51,598)
- General Counsel acquired 4,730 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
MOORE JOHN R · General Counsel
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-09-06 | Exercise or conversion : show line 1 in the form | +4,730 | $1.93 | $9,129 | 7,730 | D |
| 2022-09-06 | Sale : show line 2 in the form | −2,379 | $10.83 | $25,756 | 5,351 | D |
| 2022-09-06 | Sale : show line 3 in the form | −2,351 | $10.99 | $25,842 | 3,000 | D |
| Open-market sales · 4,730 sh · avg $10.91 · $51,598 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-09-06 | Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) | −4,730 | 127,727 | D |
Loading xslF345X03/primarydocument.xml…